Axsome Therapeutics, Inc Share Price
NASDAQ: AXSMHealthcare
Live Axsome Therapeutics, Inc Share Price Chart
O H L
Axsome Therapeutics, Inc Performance Overview
Days Range
▼
$175.87Low
$179.55High
Markets Today
| Previous Close | $179.25 |
|---|---|
| Open | $177.78 |
| Volume | 857,551 |
| Day's Range | $175.87 - $179.55 |
| 52W Range | $117.30 - $260.19 |
| Market Cap | $9.54 B |
Historical Performance
| 1M Returns | -13.97 |
|---|---|
| 3M Returns | -26.63 |
| 6M Returns | +6.38 |
| 1Y Returns | +49.00 |
| 5Y Returns | +449.34 |
| 10Y Returns | +2067.47 |
Axsome Therapeutics, Inc Fundamentals
| Market Cap | $9.54 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $638.50 M |
| ROE TTM | -2.52 |
| EPS TTM | $-3.76 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 114.31 |
| EBITDA | $-159.88 M |
| Profit Margin | -28.69 |
| Market Cap | $9.54 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $638.50 M |
| ROE TTM | -2.52 |
| EPS TTM | $-3.76 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 114.31 |
| EBITDA | $-159.88 M |
| Profit Margin | -28.69 |
Axsome Therapeutics, Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $121.46 M | $150.04 M | $170.99 M | $196.00 M | $191.20 M | $218.38 M |
| Gross Profit + | $111.67 M | $136.59 M | $159.08 M | $183.67 M | $176.48 M | $204.81 M |
| Operating Income | -$56.98 M | -$36.71 M | -$46.11 M | -$26.96 M | -$63.36 M | -$49.65 M |
| EBITDA | -$55.26 M | -$35.01 M | -$44.38 M | -$25.24 M | -$61.67 M | -$47.91 M |
| Interest Expense | $0 | -$1.83 M | $0 | $0 | $0 | -$1.54 M |
| Depreciation | $1.72 M | $1.71 M | $1.73 M | $1.72 M | $1.69 M | $1.73 M |
| Income Before Tax | -$59.41 M | -$48.93 M | -$47.23 M | -$28.13 M | -$64.54 M | -$51.19 M |
| Income Tax Expense | $0 | -$960.00 K | $0 | $430.00 K | $0 | $128.00 K |
| Net Income + | -$59.41 M | -$47.97 M | -$47.23 M | -$28.56 M | -$64.54 M | -$51.31 M |
| Net Profit Margin | -48.91% | -31.97% | -27.62% | -14.57% | -33.76% | -23.5% |
Axsome Therapeutics, Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $5.00 K | $5.00 K | $5.00 K | $5.00 K | $5.00 K | $5.00 K |
| Reserve & Surplus | -$1.18 B | -$1.23 B | -$1.28 B | -$1.31 B | -$1.37 B | -$1.42 B |
| Non-Current Liabilities | $299.55 M | $224.61 M | $235.23 M | $222.67 M | $219.81 M | $217.70 M |
| Current Liabilities | $243.91 M | $342.10 M | $360.29 M | $378.84 M | $439.21 M | $460.45 M |
| Total Liabilities | $543.47 M | $566.71 M | $595.52 M | $601.51 M | $659.02 M | $678.14 M |
| Fixed Assets | $46.09 M | $44.40 M | $42.73 M | $41.08 M | $39.51 M | $38.23 M |
| Current Assets | $494.63 M | $536.62 M | $565.34 M | $588.99 M | $611.21 M | $656.57 M |
| Total Assets | $596.67 M | $639.78 M | $669.25 M | $689.80 M | $713.61 M | $761.45 M |
Axsome Therapeutics, Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$59.41 M | -$47.97 M | -$47.23 M | -$28.56 M | -$64.54 M | -$51.31 M |
| Operating Cash Flow | -$43.38 M | -$32.42 M | $1.05 M | -$18.65 M | -$20.70 M | -$32.95 M |
| Investing Cash Flow | -$338.00 K | -$13.00 K | -$58.00 K | -$71.00 K | -$121.00 K | -$450.00 K |
| Financing Cash Flow | $29.27 M | $34.54 M | $21.27 M | $16.39 M | $2.99 M | $48.15 M |
| Change in Cash | -$14.44 M | $2.11 M | $22.26 M | -$2.34 M | -$17.83 M | $14.74 M |
Axsome Therapeutics, Inc Peer Comparison
| Company | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|
 | $15.13B | 85.26% | 15.93 | -8.35% | 0.00% |
Axsome Therapeutics, Inc Return Calculator
The Axsome Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$52,320
Invested Amount$10,000
Est. Returns$42,320
About Axsome Therapeutics, Inc
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
Popular Stocks
FAQs
What is the share price of Axsome Therapeutics, Inc today?
Axsome Therapeutics, Inc (AXSM) share price as of October 5, 2026 is $170.72. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Axsome Therapeutics, Inc?
Yes, Indian Investors can invest in the Axsome Therapeutics, Inc (AXSM) Share by opening an international trading account with Angel One.
How can I purchase Axsome Therapeutics, Inc shares in India?
Purchasing Axsome Therapeutics, Inc (AXSM) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Axsome Therapeutics, Inc (AXSM) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Axsome Therapeutics, Inc?
Yes, you can purchase fractional shares of Axsome Therapeutics, Inc (AXSM) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Axsome Therapeutics, Inc?
The market capitalization of Axsome Therapeutics, Inc on October 5, 2026, is $9.54 B.
In which sector Axsome Therapeutics, Inc belongs?
Axsome Therapeutics, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Axsome Therapeutics, Inc stocks?
In order to invest in Axsome Therapeutics, Inc (AXSM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
